231 related articles for article (PubMed ID: 12788192)
21. Preventing radiation induced xerostomia.
Koukourakis MI; Danielidis V
Cancer Treat Rev; 2005 Nov; 31(7):546-54. PubMed ID: 16257125
[TBL] [Abstract][Full Text] [Related]
22. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
[TBL] [Abstract][Full Text] [Related]
23. Is Pilocarpine Effective in Preventing Radiation-Induced Xerostomia? A Systematic Review and Meta-analysis.
Yang WF; Liao GQ; Hakim SG; Ouyang DQ; Ringash J; Su YX
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):503-11. PubMed ID: 26867879
[TBL] [Abstract][Full Text] [Related]
24. Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI).
Trotti A; Johnson DJ; Gwede C; Casey L; Sauder B; Cantor A; Pearlman J
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):257-61. PubMed ID: 9788402
[TBL] [Abstract][Full Text] [Related]
25. Randomized Double-Blind Placebo-Controlled Study of Salivary Substitute with Enzymatic System for Xerostomia in Patients Irradiated in Head and Neck Region.
Porangaba LP; de Melo Garcia F; Rabelo APAA; Andrade AP; de Abreu Alves F; Pellizzon ACA; Jaguar GC
Curr Oncol; 2024 Feb; 31(2):1102-1112. PubMed ID: 38392076
[TBL] [Abstract][Full Text] [Related]
26. Explorative study on quality of life in relation to salivary secretion rate in head and neck cancer patients treated with radiotherapy up to 2 years post treatment.
Almståhl A; Skoogh Andersson J; Alstad T; Fagerberg-Mohlin B; Finizia C
Int J Dent Hyg; 2019 Feb; 17(1):46-54. PubMed ID: 30113762
[TBL] [Abstract][Full Text] [Related]
27. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
Scrimger R; Kanji A; Parliament M; Warkentin H; Field C; Jha N; Hanson J
Am J Clin Oncol; 2007 Jun; 30(3):271-7. PubMed ID: 17551304
[TBL] [Abstract][Full Text] [Related]
28. Prevention of oral and salivary gland impairment in irradiated adolescent patients with head and neck cancer: a suggested protocol.
Davidovich E; Peretz B; Aframian DJ
Quintessence Int; 2007 Mar; 38(3):235-9. PubMed ID: 17334001
[TBL] [Abstract][Full Text] [Related]
29. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.
Rieke JW; Hafermann MD; Johnson JT; LeVeque FG; Iwamoto R; Steiger BW; Muscoplat C; Gallagher SC
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):661-9. PubMed ID: 7852133
[TBL] [Abstract][Full Text] [Related]
30. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of pilocarpine for radiation-induced xerostomia in patients with head and neck cancer: A systematic review and meta-analysis.
Cheng CQ; Xu H; Liu L; Wang RN; Liu YT; Li J; Zhou XK
J Am Dent Assoc; 2016 Apr; 147(4):236-43. PubMed ID: 26563850
[TBL] [Abstract][Full Text] [Related]
32. Drug used during radiotherapy helps reduce dry mouth problem.
Expert Rev Anticancer Ther; 2001 Jun; 1(1):4. PubMed ID: 12113130
[No Abstract] [Full Text] [Related]
33. Efficacy and economic evaluation of pilocarpine in treating radiation-induced xerostomia.
Taylor SE
Expert Opin Pharmacother; 2003 Sep; 4(9):1489-97. PubMed ID: 12943478
[TBL] [Abstract][Full Text] [Related]
34. A randomized phase III trial for alleviating radiation-induced xerostomia with chewing gum.
Kaae JK; Stenfeldt L; Hyrup B; Brink C; Eriksen JG
Radiother Oncol; 2020 Jan; 142():72-78. PubMed ID: 31606226
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of pilocarpine lozenge for post-radiation xerostomia in patients with head and neck cancer.
Taweechaisupapong S; Pesee M; Aromdee C; Laopaiboon M; Khunkitti W
Aust Dent J; 2006 Dec; 51(4):333-7. PubMed ID: 17256309
[TBL] [Abstract][Full Text] [Related]
36. Explorative study on quality of life in relation to salivary secretion rate in patients with head and neck cancer treated with radiotherapy.
Almståhl A; Alstad T; Fagerberg-Mohlin B; Carlén A; Finizia C
Head Neck; 2016 May; 38(5):782-91. PubMed ID: 25537660
[TBL] [Abstract][Full Text] [Related]
37. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction.
Valdez IH; Wolff A; Atkinson JC; Macynski AA; Fox PC
Cancer; 1993 Mar; 71(5):1848-51. PubMed ID: 8448748
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the correlation between side effects to oral mucosa, salivary glands, and general health status with quality of life during intensity-modulated radiotherapy for head and neck cancer.
Oba MK; Innocentini LMAR; Viani G; Ricz HMA; de Carvalho Reis T; Ferrari TC; de Macedo LD
Support Care Cancer; 2021 Jan; 29(1):127-134. PubMed ID: 32318870
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of oral pilocarpine in radiation-induced xerostomia in oropharyngeal carcinoma patients.
Kaur H; Singh Banipal RP; Singh H; Sonik YA; Sandhu SK
J Cancer Res Ther; 2023; 19(3):788-792. PubMed ID: 37470612
[TBL] [Abstract][Full Text] [Related]
40. [Usefulness of pilocarpine in the prevention of xerostomia in patients with head and neck cancer treated with radiotherapy. Assessment with gammagraphy and salivary flow].
Fuertes Cabero S; Setoain Perego X; Rovirosa Casino A; Mateos Fernández JJ; Fuster Pelfort D; Ferre Jorge J; Navalpotro Yagüe V; Paredes Barranco P; Ortín Pérez J; Muxí Pradas A; Pons Pons F
Rev Esp Med Nucl; 2004; 23(4):259-66. PubMed ID: 15207210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]